Reuters logo
BRIEF-CytomX achieves development milestone in collaboration with AbbVie
June 29, 2017 / 12:15 PM / in 5 months

BRIEF-CytomX achieves development milestone in collaboration with AbbVie

June 29 (Reuters) - CytomX Therapeutics Inc:

* CytomX achieves development milestone in strategic oncology collaboration with AbbVie for CD71-targeting probody drug conjugate

* CytomX Therapeutics Inc - will receive a $15 million milestone payment from AbbVie as part of 2016 strategic oncology collaboration between companies Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below